Free Trial
NYSE:SOLV

Solventum Q1 2024 Earnings Report

Solventum logo
$76.24 -2.26 (-2.88%)
Closing price 07/7/2025 03:59 PM Eastern
Extended Trading
$76.24 +0.01 (+0.01%)
As of 07/7/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum EPS Results

Actual EPS
$2.08
Consensus EPS
$1.67
Beat/Miss
Beat by +$0.41
One Year Ago EPS
N/A

Solventum Revenue Results

Actual Revenue
$2.02 billion
Expected Revenue
$1.99 billion
Beat/Miss
Beat by +$30.27 million
YoY Revenue Growth
N/A

Solventum Announcement Details

Quarter
Q1 2024
Time
Before Market Opens
Conference Call Date
Thursday, May 9, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

Solventum's Q2 2025 earnings is scheduled for Monday, August 4, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Solventum Earnings Headlines

Argus Upgrades Solventum (NYSE:SOLV) to Buy
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
See More Solventum Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solventum? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solventum and other key companies, straight to your email.

About Solventum

Solventum (NYSE:SOLV) (NYSE:SOLV) is a global specialty chemicals company primarily engaged in the production and distribution of high-performance solvents, surfactants, and related chemical intermediates. The company’s product portfolio serves a wide range of industries, including coatings and inks, personal care and cosmetics, pharmaceuticals, agrochemicals, and industrial cleaning. Solventum emphasizes customized formulations to meet specific customer requirements, addressing both performance and regulatory demands.

In addition to standard product lines, Solventum offers contract manufacturing, technical support, and laboratory services to accelerate product development and scale-up. The company operates multiple research and development centers where its teams collaborate with clients on sustainable chemistry initiatives, focusing on low-VOC (volatile organic compound) formulations, bio-based solvents, and waste-reduction processes. This commitment to innovation has positioned Solventum as a partner of choice for companies seeking environmentally responsible solutions.

Founded in 1995, Solventum has grown through organic expansion and strategic acquisitions. The company’s headquarters is located in Houston, Texas, and it maintains major production facilities in the United States, Europe, and Asia. Over the past two decades, Solventum has invested in capacity enhancements and technology upgrades to support rising demand in emerging markets, particularly in China, India, and Latin America.

Leadership at Solventum is led by Chief Executive Officer John A. Thompson, who has steered the company toward sustainable growth strategies since his appointment in 2018. Chief Financial Officer Jane L. Roberts oversees financial planning and risk management, while Chief Technology Officer Dr. Emily Chen directs research and innovation efforts. Together, the management team continues to expand Solventum’s global footprint, focusing on operational excellence and customer-centric solutions.

View Solventum Profile

More Earnings Resources from MarketBeat